Core Viewpoint - The company expects a significant increase in net profit for the first three quarters of 2025, driven by growth in its pharmaceutical and electronic materials segments [1] Financial Performance - The projected net profit attributable to the parent company is 281 million yuan, representing a year-on-year increase of 51.54% [1] - Excluding the impact of share-based payment expenses, the expected net profit is 307 million yuan, reflecting a year-on-year growth of 56.92% [1] Segment Performance - The display materials segment has maintained stable development during the reporting period [1] - The pharmaceutical and electronic materials segments have achieved substantial revenue growth, effectively contributing to the increase in net profit levels [1]
瑞联新材:预计前三季度净利润同比增长51.54%